In particular, the localised expression of VCAM-1 to areas of inflammation can be exploited to achieve specific visualisation of colitic lesions and colorectal tumours by labelling the peripheral activated vasculature associated with these disease sites. This evidence concerns the gene VCAM1 and colorectal neoplasm.